Interview with Adial Pharmaceuticals CEO Bill Stilley

HealthBiz with David E. Williams

English - June 02, 2022 09:00 - 24 minutes - 16.6 MB - ★★★★★ - 42 ratings
Management Business healthcare business health care healthcare policy entrepreneurship ceo interview Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Alzheimer's diagnosis via retinal scan. Interview with RetiSpec CEO Eliav Shaked

Next Episode: Interview with eClinical Solutions CEO Raj Indupuri

Adial Pharmaceuticals CEO Bill Stilley is leading the development of a genetically targeted therapeutic agent for alcohol use disorder. Adial is currently completing a Phase III trial to determine whether this oral medication can reduce overall alcohol use and the number of heavy drinking days.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.